HomeCBI • TLV
add
Clal Biotechnology Industries Ltd.
Previous close
ILA 37.30
Day range
ILA 38.00 - ILA 42.20
Year range
ILA 28.20 - ILA 49.00
Market cap
64.46M ILS
Avg Volume
94.23K
P/E ratio
-
Dividend yield
-
Primary exchange
TLV
Market news
Financials
Income Statement
Revenue
Net income
(ILS) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 697.50K | — |
Operating expense | 1.24M | -30.86% |
Net income | -5.18M | 74.92% |
Net profit margin | -741.94 | — |
Earnings per share | — | — |
EBITDA | -486.00K | 71.56% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(ILS) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.61M | -83.15% |
Total assets | 52.12M | -51.43% |
Total liabilities | 19.52M | -19.93% |
Total equity | 32.60M | — |
Shares outstanding | 147.86M | — |
Price to book | 2.33 | — |
Return on assets | -2.61% | — |
Return on capital | -2.66% | — |
Cash Flow
Net change in cash
(ILS) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -5.18M | 74.92% |
Cash from operations | -1.06M | 33.28% |
Cash from investing | 605.50K | -92.68% |
Cash from financing | -735.00K | 88.32% |
Net change in cash | -1.17M | -332.51% |
Free cash flow | -342.56K | 83.83% |
About
Founded
1998
Website
Employees
3